Search Results - "Ho, Anthony Dick"
-
1
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis
Published in Bone marrow transplantation (Basingstoke) (01-01-2021)“…Purpose of this single-centre retrospective study was to assess the outcome of allogeneic hematopoietic cell transplantation (alloHCT) for relapsed/refractory…”
Get full text
Journal Article -
2
HCV load as a possible prognostic factor in patients with HCV-related DLBCL
Published in Annals of hematology (01-02-2018)Get full text
Journal Article -
3
Outcome after high‐dose chemotherapy and autologous stem cell transplantation in patients with aggressive B‐cell non‐Hodgkin's lymphoma
Published in European journal of haematology (01-07-2018)“…Objective For more than two decades, high‐dose chemotherapy (HDT) and autologous blood stem cell transplantation (ABSCT) were treatment options for patients…”
Get full text
Journal Article -
4
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study
Published in Cytotherapy (Oxford, England) (2009)“…Background aims Previous studies in xenograft models have shown that human peripheral blood progenitor cells (PBPC) mobilized with the CXCR4 antagonist…”
Get full text
Journal Article -
5
CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison
Published in Blood advances (22-12-2020)“…CD19-directed chimeric antigen receptor (CAR) T-cell treatment has evolved as standard of care (SOC) for multiply relapsed/refractory (R/R) large B-cell…”
Get full text
Journal Article -
6
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma
Published in Bone marrow transplantation (Basingstoke) (01-12-2005)“…Conventional treatment or autologous transplantation has not been able to achieve long-term remission in patients with multiple myeloma (MM). Nonmyeloablative…”
Get full text
Journal Article -
7
Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25high,CD127−/low regulatory T cells in patients with active systemic lupus erythematosus
Published in Arthritis and rheumatism (01-07-2008)“…Objective CD4+,CD25high regulatory T (Treg) cells play a crucial role in the maintenance of self tolerance and prevention of organ‐specific autoimmunity. The…”
Get full text
Journal Article -
8
Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma
Published in Anti-cancer drugs (01-08-2010)“…Imexon [AOP99.0001 (4-imino-1,3-diazobicyclo[3. 1. 0]-hexan-2-one)] belongs to a novel class of promising anticancer agents that induce tumor apoptosis through…”
Get full text
Journal Article -
9
Kinetics of Peripheral Blood Stem Cell Mobilization Following G‐CSF‐Supported Chemotherapy
Published in Stem cells (Dayton, Ohio) (01-01-2003)“…It would be a clinical and economical advantage if the optimal time point of peripheral blood stem cell (PBSC) mobilization following G‐CSF‐supported…”
Get full text
Journal Article -
10
-
11
-
12
Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon
Published in Leukemia (01-10-1991)“…The bone marrow of five patients with progressive hairy cell leukemia was examined histologically and by magnetic resonance imaging in a prospective study…”
Get more information
Journal Article